Outstanding Questions in the Clinical Management of Triple-Negative Breast Cancer

J Oncol Pract. 2017 May;13(5):305-307. doi: 10.1200/JOP.2017.023341.
No abstract available

Publication types

  • Comment

MeSH terms

  • Breast Neoplasms
  • Humans
  • Receptor, ErbB-2*
  • Receptors, Estrogen
  • Triple Negative Breast Neoplasms*

Substances

  • Receptors, Estrogen
  • Receptor, ErbB-2